Mark Peek

537 total citations
9 papers, 456 citations indexed

About

Mark Peek is a scholar working on Hematology, Hepatology and Molecular Biology. According to data from OpenAlex, Mark Peek has authored 9 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Hematology, 4 papers in Hepatology and 3 papers in Molecular Biology. Recurrent topics in Mark Peek's work include Liver physiology and pathology (4 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers) and Hemophilia Treatment and Research (4 papers). Mark Peek is often cited by papers focused on Liver physiology and pathology (4 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers) and Hemophilia Treatment and Research (4 papers). Mark Peek collaborates with scholars based in United States, France and Germany. Mark Peek's co-authors include Daniel Kirchhofer, Paul Moran, Michael T. Lipari, Karen L. Billeci, Charles Eigenbrot, Bin Fan, Robert A. Lazarus, Dineli Wickramasinghe, Nerissa Mendoza and Jennifer L. Stamos and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Biochemical Journal.

In The Last Decade

Mark Peek

9 papers receiving 426 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Peek United States	9	219	189	105	65	60	9	456
Angela Tam United States	9	426 1.9×	55 0.3×	23 0.2×	25 0.4×	115 1.9×	12	634
Mary Anne Jelinek United States	9	818 3.7×	180 1.0×	18 0.2×	10 0.2×	92 1.5×	9	992
Takaaki Imamura Japan	12	351 1.6×	105 0.6×	10 0.1×	20 0.3×	181 3.0×	24	647
Daniel Corcos France	12	203 0.9×	41 0.2×	11 0.1×	28 0.4×	79 1.3×	23	381
María J. García‐Barchino Spain	9	237 1.1×	15 0.1×	41 0.4×	86 1.3×	290 4.8×	10	508
Hesham Eldaly United Kingdom	11	186 0.8×	14 0.1×	25 0.2×	36 0.6×	123 2.0×	19	441
Pietro Gangemi Italy	12	241 1.1×	44 0.2×	7 0.1×	21 0.3×	164 2.7×	15	513
A. D. Colevas United States	10	355 1.6×	17 0.1×	26 0.2×	33 0.5×	391 6.5×	24	652
Martina Almáši Czechia	13	342 1.6×	12 0.1×	291 2.8×	57 0.9×	104 1.7×	29	491
Jin-Wan Park South Korea	6	257 1.2×	18 0.1×	14 0.1×	15 0.2×	85 1.4×	38	416

Countries citing papers authored by Mark Peek

Since Specialization

Citations

This map shows the geographic impact of Mark Peek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Peek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Peek more than expected).

Fields of papers citing papers by Mark Peek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Peek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Peek. The network helps show where Mark Peek may publish in the future.

Co-authorship network of co-authors of Mark Peek

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Peek. A scholar is included among the top collaborators of Mark Peek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Peek. Mark Peek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Banerjee, Sujata, et al.. (2017). Granular Computing and Network Intensive Applications. 157–163. 17 indexed citations

2.

Kirchhofer, Daniel, Mark Peek, Michael T. Lipari, et al.. (2005). Hepsin activates pro‐hepatocyte growth factor and is inhibited by hepatocyte growth factor activator inhibitor‐1B (HAI‐1B) and HAI‐2. FEBS Letters. 579(9). 1945–1950. 129 indexed citations

3.

Kelley, Robert F., Jihong Yang, Charles Eigenbrot, et al.. (2004). Similar Molecular Interactions of Factor VII and Factor VIIa with the Tissue Factor Region that Allosterically Regulates Enzyme Activity. Biochemistry. 43(5). 1223–1229. 19 indexed citations

4.

Kirchhofer, Daniel, Xiaoyi Yao, Mark Peek, et al.. (2004). Structural and Functional Basis of the Serine Protease-like Hepatocyte Growth Factor β-Chain in Met Binding and Signaling. Journal of Biological Chemistry. 279(38). 39915–39924. 78 indexed citations

5.

Kirchhofer, Daniel, Mark Peek, Wei Li, et al.. (2003). Tissue Expression, Protease Specificity, and Kunitz Domain Functions of Hepatocyte Growth Factor Activator Inhibitor-1B (HAI-1B), a New Splice Variant of HAI-1. Journal of Biological Chemistry. 278(38). 36341–36349. 88 indexed citations

6.

Peek, Mark, et al.. (2002). Fusion of two distinct peptide exosite inhibitors of Factor VIIa. Biochemical Journal. 363(2). 387–387. 13 indexed citations

7.

Peek, Mark, Paul Moran, Nerissa Mendoza, Dineli Wickramasinghe, & Daniel Kirchhofer. (2002). Unusual Proteolytic Activation of Pro-hepatocyte Growth Factor by Plasma Kallikrein and Coagulation Factor XIa. Journal of Biological Chemistry. 277(49). 47804–47809. 59 indexed citations

8.

Kirchhofer, Daniel, Charles Eigenbrot, Michael T. Lipari, et al.. (2000). The Tissue Factor Region That Interacts with Factor Xa in the Activation of Factor VII. Biochemistry. 40(3). 675–682. 33 indexed citations

9.

Himber, Jacques, Paul Moran, Mark Peek, et al.. (1999). A Human Antibody that Binds to the γ-carboxyglutamic Acid Domain of Factor IX Is a Potent Antithrombotic In Vivo. Thrombosis and Haemostasis. 82(9). 1188–1195. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact